VOYA Investment Management
NBIX icon

VOYA Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

VOYA Investment Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Sell
86,777
-3,863
-4% -$513K 0.01% 579
2025
Q4 		$12.9M Sell
90,640
-638
-0.7% -$92.4K 0.01% 592
2025
Q3 		$12.8M Sell
91,278
-30,462
-25% -$4.13M 0.01% 600
2025
Q2 		$15.3M Sell
121,740
-27,105
-18% -$3.11M 0.02% 611
2025
Q1 		$16.5M Buy
148,845
+9,404
+7% +$1.19M 0.02% 585
2024
Q4 		$19M Buy
139,441
+16,373
+13% +$2.03M 0.02% 562
2024
Q3 		$14.2M Sell
123,068
-28,413
-19% -$3.9M 0.01% 659
2024
Q2 		$20.9M Buy
151,481
+2,498
+2% +$343K 0.02% 529
2024
Q1 		$20.5M Buy
148,983
+14,237
+11% +$1.94M 0.02% 540
2023
Q4 		$17.8M Sell
134,746
-43,843
-25% -$5.05M 0.02% 557
2023
Q3 		$20.1M Buy
178,589
+7,804
+5% +$822K 0.02% 496
2023
Q2 		$16.1M Buy
170,785
+5,297
+3% +$518K 0.02% 583
2023
Q1 		$16.8M Buy
165,488
+3,677
+2% +$383K 0.02% 581
2022
Q4 		$19.3M Buy
161,811
+36,761
+29% +$4.31M 0.02% 545
2022
Q3 		$13.3M Buy
125,050
+44,388
+55% +$4.5M 0.02% 615
2022
Q2 		$7.86M Buy
80,662
+9,359
+13% +$864K 0.02% 569
2022
Q1 		$6.68M Buy
71,303
+7,901
+12% +$670K 0.01% 751
2021
Q4 		$5.4M Buy
63,402
+24,140
+61% +$2.22M 0.01% 814
2021
Q3 		$3.77M Sell
39,262
-910
-2% -$86K 0.01% 940
2021
Q2 		$3.91M Buy
40,172
+9,430
+31% +$904K 0.01% 950
2021
Q1 		$2.99M Sell
30,742
-1,707
-5% -$179K 0.01% 1012
2020
Q4 		$3.11M Sell
32,449
-1,673
-5% -$162K 0.01% 969
2020
Q3 		$3.28M Sell
34,122
-1,371
-4% -$159K 0.01% 873
2020
Q2 		$4.33M Buy
35,493
+2,825
+9% +$312K 0.01% 797
2020
Q1 		$2.83M Sell
32,668
-815
-2% -$79.8K 0.01% 851
2019
Q4 		$3.6M Sell
33,483
-11,513
-26% -$1.21M 0.01% 891
2019
Q3 		$4.05M Sell
44,996
-5,578
-11% -$521K 0.01% 848
2019
Q2 		$4.27M Buy
50,574
+550
+1% +$45.2K 0.01% 847
2019
Q1 		$4.41M Buy
50,024
+11,689
+30% +$977K 0.01% 822
2018
Q4 		$2.74M Sell
38,335
-15,508
-29% -$1.49M 0.01% 925
2018
Q3 		$6.62M Buy
53,843
+507
+1% +$57.5K 0.01% 738
2018
Q2 		$5.24M Sell
53,336
-4,381
-8% -$392K 0.01% 804
2018
Q1 		$4.79M Buy
57,717
+1,134
+2% +$95.8K 0.01% 820
2017
Q4 		$4.39M Buy
56,583
+18,707
+49% +$1.28M 0.01% 854
2017
Q3 		$2.32M Buy
37,876
+3,971
+12% +$210K 0.01% 990
2017
Q2 		$1.56M Sell
33,905
-917
-3% -$44.5K ﹤0.01% 1141
2017
Q1 		$1.51M Sell
34,822
-1,994
-5% -$85.4K ﹤0.01% 1138
2016
Q4 		$1.43M Sell
36,816
-163,648
-82% -$7.41M ﹤0.01% 1164
2016
Q3 		$10.2K Sell
200,464
-199,091
-50% -$9.92M 0.02% 584
2016
Q2 		$18.2M Sell
399,555
-159,975
-29% -$7.37M 0.04% 386
2016
Q1 		$22.1M Buy
559,530
+24,300
+5% +$964K 0.05% 313
2015
Q4 		$30.3M Sell
535,230
-42,200
-7% -$2.14M 0.07% 257
2015
Q3 		$23M Buy
577,430
+188,711
+49% +$9.12M 0.06% 303
2015
Q2 		$18.6M Buy
388,719
+348,336
+863% +$14.8M 0.04% 369
2015
Q1 		$1.6M Hold
40,383
– – ﹤0.01% 1189
2014
Q4 		$902K Hold
40,383
– – ﹤0.01% 1506
2014
Q3 		$633K Hold
40,383
– – ﹤0.01% 1739
2014
Q2 		$599K Hold
40,383
– – ﹤0.01% 1841
2014
Q1 		$650K Hold
40,383
– – ﹤0.01% 1774
2013
Q4 		$377K Hold
40,383
– – ﹤0.01% 2170
2013
Q3 		$457K Hold
40,383
– – ﹤0.01% 1973
2013
Q2 		$540K Buy
+40,383
New +$496K ﹤0.01% 1765

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's NBIX Position: Q1 2026 in Review

VOYA Investment Management reduced its Neurocrine Biosciences (NBIX) stake by 4.3% in Q1 2026, selling an estimated $513K and leaving 86,777 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #579.

VOYA Investment Management first reported a position in NBIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.3M in Q4 2015. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • VOYA Investment Management held 86,777 shares of Neurocrine Biosciences worth $11.4M as of Q1 2026.
  • VOYA Investment Management sold 3,863 Neurocrine Biosciences shares in Q1 2026, an estimated $513K.
  • Neurocrine Biosciences made up 0.01% of VOYA Investment Management's portfolio in Q1 2026, its #579 holding.
  • VOYA Investment Management first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Neurocrine Biosciences position peaked at $30.3M in Q4 2015.
  • 694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.